Table 2.
Treatment of NB due to lumbar spine diseases.
| Category | Method |
|---|---|
| Conservation treatment | Bladder reflex trigger, behavioral training, penis sleeves and external urinary collectors, and modifying drinking habits |
| Drug therapy | |
| Anticholinergics | Darifenacin, fesoterodine, oxybutynin, propiverine, solifenacin, tolterodine and trospium chloride |
| β3 adrenergic receptor agonists | Mirabegron and vibegron |
| Alpha-adrenergic antagonists | Tamsulosin and terazosin |
| Intracavitary perfusion therapy | Oxybutynin, capsaicin and its analogs and local anesthetic buprocaine hydrochloride |
| Others | Desmopressin, potassium channel opener and neurokinin receptor antagonist |
| Urethral catheterization treatment | Clean intermittent catheterization, indwelling urethral catheters, suprapubic catheters and external condom catheters |
| Surgical treatment | |
| Procedures to expand bladder capacity | Botulinum toxin bladder wall injection/bladder chemoprotection and bladder dilation |
| Procedures to increase urethral control | Artificial urethral sphincter implantation, periurethral filler injection, urethral sling and femoral thin muscle urethral myoplasty |
| Modalities to manage voiding disorders | Neuromodulation, external urethral sphincterotomy and CUD |
NB, neurogenic bladder; CUD, continuous urinary diversion.
This work is licensed under a